Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 March 2023 | Story Kekeletso Takang and Lacea Loader | Photo UFS Photo Archive
Tate_Makgoe
Tate Makgoe, late MEC of Education in the Free State.

The management of the University of the Free State (UFS) is shocked and saddened to learn of the untimely passing of Tate Makgoe, member of the Executive Council (MEC) for Education in the Free State, who passed away on Sunday 5 March 2023 after a car accident.

MEC Makgoe was a UFS Council member as representative of the Free State Premier for two terms, from 1 November 2010 to 31 December 2018. He was also a member of the Executive Committee of Council in his second term.

“On behalf of the UFS Council, the university management, and the university community, I would like to express our heartfelt condolences to MEC Makgoe’s family, Premier Mxolisi Dukwana, and the Executive Council of the Free State, as well as the Free State education sector at large, for the loss of a great leader,” said Prof Francis Petersen, UFS Rector and Vice-Chancellor.  

MEC Makgoe had a strong relationship with the UFS, which saw him collaborating on numerous projects, including the Internet Broadcast Project from 2012 to 2022, which was aimed at supporting Grade 12 learners and teachers.

Prof Petersen acknowledged MEC Makgoe for his contributions to the university, the institution’s Council, and the province’s education sector. “We are proud to have been associated with MEC Makgoe. Not only in his capacity as MEC, but also as alumnus. He held an Honours degree in Commerce from the UFS and was registered for a PhD in Education Leadership and Policy Studies at the university at the time of his passing. In 2013, he received a Cum Laude Award during the Chancellor's Distinguished Alumni Awards ceremony,” said Prof Petersen.

Through continued collaboration and under his leadership, the Free State reclaimed its top spot in the National Senior Certificate examination results in 2019 and has maintained it to date. “This would not have been possible without the leadership of MEC Makgoe; we salute him for the significant role he played, and for his contribution to the success of the province over the past few years,” said Prof Petersen.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept